Patents by Inventor Daniel HALBIG
Daniel HALBIG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240424216Abstract: In one instance, disclosed herein is an auto-injector, the auto-injector including: a housing; a container disposed within the housing, the container configured to store a medicament; a canister disposed within the housing, the canister configured to release a pressurized medium to expel the medicament from the container; a shroud coupled to the housing, the shroud configured to move between a first position and a second position relative to the housing to cause the pressurized medium to be released by the canister; and a mandrel assembly disposed within the housing, the mandrel assembly configured to urge the shroud outward relative to the housing toward the first position after the pressurized medium is released by the canister.Type: ApplicationFiled: June 20, 2024Publication date: December 26, 2024Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Daniel HALBIG, Alexander ROUMANIDAKIS, Bryan GRYGUS, Danielle Laiacona, Sindhuja Kuchibhatla, John Burke, Daniel O’Connell-Govan
-
Publication number: 20240382677Abstract: An injection device may include a housing, a container disposed within the housing, the container enclosing a fluid and having a first end and a second end, a conduit movable relative to the container, wherein the conduit is not in fluid communication with the fluid enclosed by the container while in a first position, and is in fluid communication with the fluid enclosed by the container and configured to deliver the fluid from the container to a patient while in a second position, and a lock that is removable from the housing, the lock having a first portion and a second portion.Type: ApplicationFiled: May 16, 2024Publication date: November 21, 2024Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. GRYGUS, Trevor Langley, Daniel Halbig, Ross Kenyon, Alfred Marino, Wayne Phillips, Jeff Moore, Sten Nygaard, Jan Norup, David Farrage, Jeremy Odegard, Jeremy McNamara
-
Publication number: 20240350748Abstract: Needle spacers for use in administering subcutaneous injections, as well as subcutaneous injection systems including such needle spacers, are disclosed. In certain embodiments, the needle spacer comprises a first portion configured to engage a hub of a needle that comprises such a hub; and a second portion coupled to the first portion and extending distally therefrom, the second portion including a skin-contacting surface disposed on a distal end thereof, wherein the skin-contacting surface is configured to engage a surface of skin of a subject. The second portion is configured to maintain a predetermined distance between the hub of the needle and the surface of the skin, and to permit insertion of the needle to a depth of about 4 mm to about 8 mm below the surface of the skin during administration of a subcutaneous injection via the needle.Type: ApplicationFiled: April 18, 2024Publication date: October 24, 2024Inventors: Daniel HALBIG, Matthew PAUSLEY, Thomas MADDEN, Alexander ROUMANIDAKIS, Sarah ELLIS, Eric HOLOWKA, Trevor LANGLEY, Jessica MASTROPIETRO, Megan THOMPSON
-
Publication number: 20240278712Abstract: A method for operating a taillight of a motor vehicle, wherein the taillight, in particular in addition to a functional light source assigned to at least one further light function, has a taillight source assigned to a taillight function, having a plurality of lighting regions that can be controlled independently with respect to operation and brightness, wherein at least one environment sensor of the motor vehicle records sensor data describing other traffic participants behind within a predefined distance range from the rear of the motor vehicle, wherein if at least one activation criterion evaluating the sensor data and checking for the presence of at least one further traffic participant within a predetermined distance range from the rear of the motor vehicle, a brightness-increasing switching operation, in particular an activation and/or a dimming, of a second lighting region of the taillight source which was previously inactive or is operating with lower brightness than at least one other, first lightingType: ApplicationFiled: June 17, 2021Publication date: August 22, 2024Applicant: AUDI AGInventors: Valentin SCHMIDT, Daniel HALBIG, Ernst REITER, Roman HORST, Viktor HAHN
-
Publication number: 20240075204Abstract: An auto-injector may include a container capable of comprising a medicament; a shuttle coupled to the container and on a horizontal path with a first state and a second state; an energy source configured to release energy to translate the container and to translate the shuttle, preferably the energy source is pressurized fluid from a can; an impediment preventing horizontal movement of the shuttle before activation of the auto-injector; and a needle having a first end configured to extend out of the auto-injector, and a second end configured to extend into the container, wherein the second end of the needle and the container are not in fluid communication with one another before activation of the auto-injector.Type: ApplicationFiled: June 29, 2023Publication date: March 7, 2024Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Daniel HALBIG, Bryan GRYGUS, Trevor LANGLEY, Andrew DUMONT, Bart E. BURGESS, Matthew PAUSLEY, Ross KENYON
-
Publication number: 20230233770Abstract: A drug delivery device is disclosed, wherein the device comprises a housing; a product container arranged in the housing; a plunger rod partially disposed inside the product container; and a thumb pad configured to receive a portion of the plunger rod, wherein the thumb pad and the plunger rod are configured to transition from a first state to a second state, wherein at the first state, the plunger rod is prevented from moving in a proximal direction, and at the second state, the plunger rod moves freely in a proximal direction.Type: ApplicationFiled: January 25, 2023Publication date: July 27, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Trevor LANGLEY, Bryan GRYGUS, Daniel HALBIG, Paige WAECHTER, Andrew DUMONT, Parker VALDEZ, Sindhuja KUCHIBHATLA
-
Publication number: 20230225944Abstract: A vial adapter assembly that includes a housing, a first receptacle formed within the housing and configured to receive a first vial within the housing, and a second receptacle formed within the housing and configured to receive a second vial within the housing. An opening of the first receptacle and an opening of the second receptacle is in fluid communication with the upper surface of the housing. The vial adapter assembly includes a cap that is coupled and movable relative to the housing from a closed configuration to an open configuration. In the closed configuration, the cap is configured to cover the opening of the first receptacle and the opening of the second receptacle on the upper surface. In the open configuration, the cap is configured to uncover the opening of the first receptacle and the opening of the second receptacle, and expose the upper surface.Type: ApplicationFiled: January 17, 2023Publication date: July 20, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bryan GRYGUS, Daniel HALBIG, Eric HOUDE, Prithvi SINGH, Paige WAECHTER, Parker VALDEZ, Sandy SPENCER, Sindhuja KUCHIBHATLA, Trevor LANGLEY
-
Publication number: 20230105585Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: ApplicationFiled: December 8, 2022Publication date: April 6, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. GRYGUS, Alfred MARINO, Rachel P. ARNOTT, Scott BARTON, Bart E. BURGESS, Richard GILDERSLEEVE, Alexei GORALTCHOUK, Daniel HALBIG, Christopher KANEL, Trevor LANGLEY
-
Patent number: 11547801Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: GrantFiled: May 4, 2018Date of Patent: January 10, 2023Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Bryan C. Grygus, Alfred Marino, Rachel P. Arnott, Scott Barton, Bart E. Burgess, Richard Gildersleeve, Alexei Goraltchouk, Daniel Halbig, Christopher Kanel, Trevor Langley
-
Publication number: 20220370721Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.Type: ApplicationFiled: August 1, 2022Publication date: November 24, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Trevor LANGLEY, Justin BECHSTEIN, Jeremy ODEGARD, Sibgat ULLA, Daniel HALBIG, Bryan GRYGUS, Prithvi SINGH, Andrew DUMONT, David NETT, Tasha GILLUM, Ryan AINSWORTH
-
Patent number: 11439758Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.Type: GrantFiled: June 22, 2021Date of Patent: September 13, 2022Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Trevor Langley, Justin Bechstein, Jeremy Odegard, Sibgat Ulla, Daniel Halbig, Bryan Grygus, Prithvi Singh, Andrew Dumont, David Nett, Tasha Gillum, Ryan Ainsworth
-
Publication number: 20220203032Abstract: An auto-injector may include a container capable of comprising a medicament; a shuttle coupled to the container and on a horizontal path with a first state and a second state; an energy source configured to release energy to translate the container and to translate the shuttle, preferably the energy source is pressurized fluid from a can; an impediment preventing horizontal movement of the shuttle before activation of the auto-injector; and a needle having a first end configured to extend out of the auto-injector, and a second end configured to extend into the container, wherein the second end of the needle and the container are not in fluid communication with one another before activation of the auto-injector.Type: ApplicationFiled: December 29, 2021Publication date: June 30, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Daniel HALBIG, Bryan GRYGUS, Trevor LANGLEY, Andrew DUMONT, Bart E. BURGESS, Matthew PAUSLEY, Ross KENYON
-
Publication number: 20220193343Abstract: An auto-injector may include a housing having a longitudinal axis and a transverse axis, the housing having a shorter dimension along the transverse axis than along the longitudinal axis, wherein the transverse axis is perpendicular to the longitudinal axis; a flowpath having a first end and a second end; and a container enclosing a first fluid, the container extending from a first end toward a second end along or parallel to the longitudinal axis and being movable from a first position to a second position along or parallel to the longitudinal axis, the container being fluidly isolated from the flowpath in the first position and fluidly connected to the flowpath in the second position.Type: ApplicationFiled: December 29, 2021Publication date: June 23, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bart BURGESS, Bryan GRYGUS, Daniel HALBIG, Ross KENYON, Trevor LANGLEY, Jeremy MCNAMARA, Matthew PAUSLEY, Andrew DUMONT, Paige WAECHTER, John BURKE, Martin BONTOFT, Craig MCGARRELL, Scott MARTIN, James Nicholas MOWER, James Cunningham GLENCROSS, James Donald MCLUSKY, Andrew LABAT-ROCHECOUSTE, Tim QUIGG, Matt HILL, Matthew PHILLIPPO, Kirsty WYNNE
-
Publication number: 20220160968Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.Type: ApplicationFiled: December 3, 2021Publication date: May 26, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Trevor LANGLEY, Justin BECHSTEIN, Jeremy ODEGARD, Sibgat ULLA, Daniel HALBIG, Bryan GRYGUS, Prithvi SINGH, Andrew DUMONT, David NETT, Tasha GILLUM, Ryan AINSWORTH
-
Publication number: 20220118177Abstract: An auto-injector may include a housing having a longitudinal axis and a transverse axis, the housing having a shorter dimension along the transverse axis than along the longitudinal axis, wherein the transverse axis is perpendicular to the longitudinal axis; a flowpath having a first end and a second end; and a container enclosing a first fluid, the container extending from a first end toward a second end along or parallel to the longitudinal axis and being movable from a first position to a second position along or parallel to the longitudinal axis, the container being fluidly isolated from the flowpath in the first position and fluidly connected to the flowpath in the second position.Type: ApplicationFiled: December 29, 2021Publication date: April 21, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bart BURGESS, Bryan GRYGUS, Daniel HALBIG, Ross KENYON, Trevor LANGLEY, Jeremy MCNAMARA, Matthew PAUSLEY, Andrew DUMONT, Paige WAECHTER, John BURKE, Martin BONTOFT, Craig MCGARRELL, Scott MARTIN, James Nicholas MOWER, James Cunningham GLENCROSS, James Donald MCLUSKY, Andrew LABAT-ROCHECOUSTE, Tim QUIGG, Matt HILL, Matthew PHILLIPPO, Kirsty WYNNE
-
Publication number: 20210330887Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.Type: ApplicationFiled: June 22, 2021Publication date: October 28, 2021Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Trevor LANGLEY, Justin BECHSTEIN, Jeremy ODEGARD, Sibgat ULLA, Daniel HALBIG, Bryan GRYGUS, Prithvi SINGH, Andrew DUMONT, David NETT, Tasha GILLUM, Ryan AINSWORTH